International Patent: NOVEL TCO-FUNCTIONALIZED GLYCAN ENGINEERED IMMUNOGLOBULIN MOLECULES, NOVEL TCO-FUNCTIONALIZED SACCHARIDE COMPOUNDS FOR PREPARING THE SAME, AND NOVEL ANTIBODY PAYLOAD CONJUGATES

GENEVA, July 6 -- VERAXA BIOTECH GMBH filed a patent application (EP2025/088925) for “NOVEL TCO-FUNCTIONALIZED GLYCAN ENGINEERED IMMUNOGLOBULIN MOLECULES, NOVEL TCO-FUNCTIONALIZED SACCHARIDE COMPOUNDS FOR PREPARING THE SAME, AND NOVEL ANTIBODY PAYLOAD CONJUGATES”. With publication no. WO/2026/139575, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07H 19/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....